Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

352 ARTÍCULOS , VIENDO DEL 226 AL 240

[Current Status and Future Perspectives of Biomarkers in Alzheimer's Disease Diagnosis]

Ishiguro T, Kasuga K.

No Shinkei Geka. 2025 Sep;53(5):923-931. doi: 10.11477/mf.030126030530050923.

Research Progress on Alzheimer's Disease Biomarkers Based on the ATX(N) Framework

Cao H, Zhang W, Lin J, Yu E.

Discov Med. 2025 Feb;37(193):258-275. doi: 10.24976/Discov.Med.202537193.21.

Advanced biomarkers: Beyond amyloid and tau: Emerging non-traditional biomarkers for alzheimer`s diagnosis and progression

Afrin MR, Upadhyaya PG, Hashim A, Bhattacharya K, Chanu NR, Das D, Khanal P, Deka S.

Ageing Res Rev. 2025 Jun;108:102736. doi: 10.1016/j.arr.2025.102736. Epub 2025 Mar 22.

Alzheimer's disease biomarkers and their current use in clinical research and practice

Hunter TR, Santos LE, Tovar-Moll F, De Felice FG.

Mol Psychiatry. 2025 Jan;30(1):272-284. doi: 10.1038/s41380-024-02709-z. Epub 2024 Sep 4.

Neutrophil-to-Lymphocyte Ratio in the Alzheimer's Disease Continuum

Aprile D, De Marchi F, Menegon F, Comi C, Tondo G.

Int J Mol Sci. 2025 May 28;26(11):5157. doi: 10.3390/ijms26115157.

Proteomic Insight Into Alzheimer's Disease Pathogenesis Pathways

Ryu T, Kim K, Asiimwe N, Na CH.

Proteomics. 2025 Nov;25(21-22):214-229. doi: 10.1002/pmic.202400298. Epub 2025 Jan 10.

Early detection of Alzheimer's disease: From multiplex assays and imaging to point of care devices and AI-based functional monitoring

Teipel S, Singh D, Dubbelman MA, Pan G, Tang Y, König A.

J Alzheimers Dis. 2025 Nov;108(1_suppl):S5-S7. doi: 10.1177/13872877251383339. Epub 2025 Oct 7.

Serum proteomics reveals early biomarkers of Alzheimer's disease: The dual role of APOE-ε4

Ma YN, Xia Y, Karako K, Song P, Tang W, Hu X.

Biosci Trends. 2025 Mar 6;19(1):1-9. doi: 10.5582/bst.2024.01365. Epub 2025 Jan 23.

Unlocking the Future of Alzheimer's Disease: Innovations in Diagnosis and Therapy

Mehndiratta MM, Singla M, Dixit A.

J Assoc Physicians India. 2025 Aug;73(8):92-97. doi: 10.59556/japi.73.1075.

Central Nervous System-Derived Extracellular Vesicles as Biomarkers in Alzheimer's Disease

Yu Y, Wang Z, Chai Z, Ma S, Li A, Li Y.

Int J Mol Sci. 2025 Aug 26;26(17):8272. doi: 10.3390/ijms26178272.

The impact of real-world evidence in implementing and optimizing Alzheimer's disease care

Hampel H, Li G, Mielke MM, Galvin JE, Kivipelto M, Santarnecchi E, Babiloni C, Devanarayan V, Tkatch R, Hu Y, Kurzman R, Cho M, Vandercappellen J, Nakamura Y, Bell J, Mattke S, Toschi N.

Med. 2025 May 9;6(5):100695. doi: 10.1016/j.medj.2025.100695.

Proteome-Based Biomarkers for Alzheimer's Disease: Old Acquisitions and Innovative Proposals

Magnelli V, Pagano CA, Sabbatini M.

Int J Mol Sci. 2025 Dec 1;26(23):11654. doi: 10.3390/ijms262311654.

Prognostic Value of A/T/N Biomarkers: Comparing Plasma and Imaging Modalities in Alzheimer Disease

Yim S, Gu Y, Kang H, Shin D, Jang H, Yoo H, Zetterberg H, Blennow K, Gonzalez-Ortiz F, Ashton NJ, Weiner MW, Day TA, Lee EH, Na DL, Kim HJ, Kang SH, Kim KW, Kim YJ, Kim Y, Kim J, Chun MY, Jung NY, Cho SH, Kim JP, Yun J, Seo SW; K-ROAD study groups.

Clin Nucl Med. 2025 Dec 1;50(12):1120-1129. doi: 10.1097/RLU.0000000000006088. Epub 2025 Sep 1.

Clinical use of biomarkers in the era of Alzheimer's disease treatments

VandeVrede L, Schindler SE.

Alzheimers Dement. 2025 Jan;21(1):e14201. doi: 10.1002/alz.14201. Epub 2024 Dec 30.

A systematic comparison of ATN biomarkers for monitoring longitudinal cognitive changes in Alzheimer's disease

Biel D, Steward A, Dewenter A, Dehsarvi A, Zhu Z, Roemer-Cassiano SN, Frontzkowski L, Hirsch F, Palleis C, Höglinger G, Brendel M, Franzmeier N; Alzheimer's Disease Neuroimaging Initiative (ADNI).

Alzheimers Dement. 2025 Oct;21(10):e70783. doi: 10.1002/alz.70783.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias